You are here: Findit home » QuVa Pharma, Inc
 
RTA Intravenous Dexamethasone
Outsourced Compounding Services (503B)

QuVa Pharma provides dexamethasone phosphate as a compounded sterile product in a ready-to-administer IV bag, now available for order under FDA Drug Shortage guidelines. This compounded sterile product (CSP) is available as 6 mg in 25 mL 0.9% sodium chloride IV bag. Updated recommendations for the COVID-19 Treatment Guidelines Panel from The National Institutes of Health and the World Health Organization Panel include systemic corticosteroids, like dexamethasone 6 mg daily, for hospitalized patients with severe and critical COVID-19.


QuVa Pharma, Inc

Product Images: (click to enlarge)
 

Current Issue